ID   SK-N-SH D
AC   CVCL_B0GN
SY   SK-N-SHD
DR   cancercelllines; CVCL_B0GN
DR   Wikidata; Q108821310
RX   Patent=US10591466;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-5010.
CC   Population: Caucasian.
CC   Characteristics: Can naturally differentiate as neuron-like cells (Patent=US10591466).
CC   Sequence variation: Mutation; HGNC; 427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
RX   Patent=US10591466;
RA   Prehaud C., Lafon M., Ceccaldi P.-E., Afonso P.V., Lafaye P.;
RT   "In vitro blood-brain barrier model.";
RL   Patent number US10591466, 17-Mar-2020.
//